Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp127 | Diabetes: Late Complications | ECE2019

Genetic polymorphisms in patients with type 2 diabetes mellitus and coronary heart disease

Shyshko Volha , Mokhort Tatjana , Tsataeva Natalia , Konstantinova Elena , Gonchar Alexander

It is known that presence of certain genetic polymorphism plays important role in development of chronic complications in patients with type 2 diabetes (T2D).Aim: To analyze distribution of VEGF G/C polymorphisms and PAI-1 4G/5G polymorphisms in patients with T2D and IHD.Materials and methods: The following groups of studies were formed: 1 – 24 almost healthy people; 2 – 28 patients with prediabetes; 3 – 37 patients ...

ea0049ep663 | Obesity | ECE2017

Results of computer-assisted intravital microscopy in overweight and obesity

Shyshko Volha , Mokhort Tatjana , Konstantinova Elena , Tsapaeva Natalia

Rationale: Obesity, prediabetes and diabetes are strongly associated with microcirculation (MC) abnormalities. It is known that pathological changes in microvessels predispose to CHD, CKD and retinopathy. Also it is widely recognized that biochemical and immunological changes accompanied with obesity and overweight lead to MC damage.ObjectiveOf the study was to assess changes in MC in patients with overweight and obesity.<p cla...

ea0041ep454 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

PAI-1 polymorphism in patients with diabetes

Shyshko Volha , Mokhort Tatjana , Gonchar Alexander , Konstantinova Elena , Tsapaeva Natalia

Background: Plasminogen activator inhibitor-1 (PAI-1) refers to group of is a serine protein inhibitors. It inhibits fibrinolysis and contributes to angiogenesis and atherogenesis processes. 4G/5G polymorphism was found to be associated with increased risk for cardiovascular diseases. It was of special interest to study PAI-1 polymorphism in patients with diabetes.Aim: Aim to study PAI-1 polymorphism in patients with type 2 diabetes (T2D) and concomitant...

ea0059p105 | Diabetes &amp; cardiovascular | SFEBES2018

State of glutathione system in patients with type 2 diabetes

Shyshko Volha , Mokhort Tatjana , Buko Inna , Konstantinova Elena , Tsapaeva Natalia

Materials and methods: Included patients were divided into … groups: group 1 – 41 almost healthy person (control group), group 2 – 59 patients with prediabetes, group 3 – 41 patients with T2D, group 4 – 40 patients with T2D and CHD and group 5 – 88 patients with CHD. Activities of glutathione peroxidase (GP, mmol/min) and glutathione reductase (GR, mmol/min) and concentrations of reduced glutathione (GSH, mmol/l), oxidized glutathione (GSSG, mmol...

ea0037ep369 | Diabetes (pathiophysiology &amp; epitemiology) | ECE2015

The state of superoxidedismutase activity as marker of oxidative stress in patients with impaired glycaemic states

Shyshko Volha , Mokhort Tatjana , Tsapaeva Natalia , Buko Inna , Konstantinova Elena

One of the key enzymes of antioxidant system is superoxide dismutase (SOD) that catalyses dismutation of superoxide anionic radical (O2−)l to molecular oxygen (O2) and hydrogen (H2O2). It was revealed that activity of SOD is decreased in patients with decompensated type 2 diabetes (T2D) but there is insufficient data about enzyme activity in compensated states and prediabetes.Purpose: To analys...

ea0035p360 | Diabetes (epidemiology, pathophysiology) | ECE2014

Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more significant microcirculation abnormalities

Shyshko Volha , Mokhort Tatjana , Konstantinova Elena , Tsapaeva Nataly

It is known that patients with prediabetes (impaired glucose tolerance and impaired fasting glucose) ant type 2 diabetes (T2D) have micro-and macrovascular complications. It may be assumed that vascular changes begin in the smallest vessels that leads to microcirculation abnormalities.Purpose: To estimate microcirculation abnormalities in patients with prediabetes and T2D and concomitant atherosclerosis.Materials and methods: One h...

ea0035p438 | Diabetes complications | ECE2014

Vascular endothelial growth factor polymorphism +405 G/C is associated with early stage of diabetic nephropathy in patients with type 2 diabetes

Shyshko Volha , Mokhort Tatjana , Gonchar Alexander , Tsapaeva Natalia , Konstantinova Elena

Background: One of the basic genetic factors that impact on development of diabetic nephropathy is enhanced expression of vascular endothelial growth factor (VEGF).Objective: To study association between VEGF polymorphism +405 G/C and early stage of chronic kidney disease (CKD) in patients with impaired glycemic states.Materials and methods: 73 included patients were divided into three groups: group 1–26 patients with prediabe...

ea0056p386 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Changes in the glutathione system in patients with impaired carbohydrate metabolism

Shyshko Volha , Mokhort Tatjana , Buko Inna , Konstantinova Elena , Tsapaeva Natalia , Sazonava Alena

Introduction: Many studies have found that markers of oxidative stress (OS) are significantly increased in diabetes mellitus, but only a limited number of studies describe the disturbance of OS in pre-diabetes.Objective: To study the state of the glutathione system in patients with disorders of carbohydrate metabolism and concomitant diseases of the cardiovascular system (CVS).Materials and methods: 181 patients were included under...